Artificial Kidney Market Share

Global Artificial Kidney Market Overview

Artificial Kidney Market Size was valued at USD 0.1 Billion in 2022. The Artificial Kidney market industry is projected to grow from USD 0.16 Billion in 2023 to USD 7.00 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 60.33% during the forecast period (2024 - 2032). An increase in the case of kidney-related diseases and low availability of kidney donors, and rising R&D to improve the process of dialysis are the key market drivers enhancing the growth of market. 

Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review

Artificial Kidney Market Trends

• Growing cases of kidney-related diseases are driving the market growth

Market CAGR for artificial kidneys is being driven by the rising cases of kidney-related diseases. The rising number of patients distressed from kidney-related throughout the world and the minimum availability of kidney donors is the factor boosting the demand and growth of the artificial kidney market. There is an increase in patients agony from renal failure and chronic kidney cases, contributing to the growth of the artificial kidney market. The R&D for the dialysis process and awareness regarding renal failure disease and changing lifestyles are boosting the market growth.

An artificial kidney is a medical device allowing the assistance of dialysis at any time. In order to improve the process of dialysis, R&D activities are being done continuously. The kidney is not able to perform its functions like filtering and removing blood waste and other fluids at the end-stage of kidney disease. Hence they require dialysis treatment. The fluid and metabolic waste can be eliminated by dialysis, but they are unable to compensate for the loss of kidney functions like endocrine function, regulating metabolism, and homeostasis. The artificial kidney function assists the human body in living healthy and safe life; it reduces hospital visits for performing dialysis. The rising geriatric population and increase in kidney disorders are increasing the adoption of dialysis. Growth in the development of technologies and innovations in artificial kidney devices and related fields is fueling the market.

An increasing number of kidney diseases are leading to high expenditures on healthcare owing to the high costs of treatment, thus boosting the adoption of the wearable artificial kidney market. The Centers for the Disease Control and Prevention (CDC), in 2019, anticipated that people being affected due to chronic kidney disease were over 30 million; this prevalence is due to the sedentary lifestyle and rising consumption of fast food and packaged food having a high levels of calcium and other minerals. The wearable kidney is a portable medical device that allows patients to witness the benefits of dialysis at home while doing their day-to-day work. Thus, improving the life of patients suffering from renal diseases as it improves physiological aspects by minimizing hypertension. It also reduces the retention of sodium and reduces the risk of vascular diseases and stroke; this process costs minimum than the treatment available for renal failure patients.

The increasing investment by the key market players for technological advancements and R&D activities to innovate and develop cost-effective products. Thus, driving the Artificial Kidney market revenue.

Artificial Kidney Market Segment Insights

Artificial Kidney Type Insights

The Artificial Kidney market segmentation, based on type, includes Wearable Artificial Kidney and Implantable Artificial Kidneys. The wearable artificial kidney segment dominates the market, accounting for the largest market revenue due to the rising renal and kidney disorder cases leading to a drastic rise in patients suffering from these diseases. On the other hand, another type of artificial kidney, implantable artificial kidney, is under trial; they are undergoing clinical trials in humans and is anticipated to get FDA approval by the end of the review period. The implantable artificial is anticipated to grow at the fastest CAGR upon the approval of the FDA.

Artificial Kidney Dialysis Insights

 The Artificial Kidney market segmentation, based on dialysis, includes Hemodialysis and Peritoneal Dialysis. Hemodialysis segment accounts for the largest market share as there is a large number of hemodialysis procedures taking place. Peritoneal dialysis is anticipated to grow at a faster rate as it does not require regular visits to a dialysis unit and can be carried out at home.

Figure 1: Artificial Kidney Market, by Distribution Channel, 2022 & 2032 (USD Billion) 

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Artificial Kidney Regional Insights

By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Artificial Kidney market, dominates the market due to the increased research and development activities by the research centers for innovating artificial kidneys. The region has a rising number of patients suffering from diseases related to the kidneys. They have easy availability of advanced healthcare facilities.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: Artificial Kidney MARKET SHARE BY REGION 2022 (USD Billion) 

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Europe's Artificial Kidney market accounts for the second-largest market share due to the growing cases of diseases related to kidneys and rapid technological developments in the artificial kidney market. Further, the German Artificial Kidney market held the largest market share, and the UK Artificial Kidney market was the rapid-growing market in the European region.

The Asia-Pacific Artificial Kidney Market is expected to grow at the fastest CAGR from 2024 to 2032. This is due to rising healthcare expenditure and growth in the presence of kidney disease in the region. Moreover, China’s Artificial Kidney market held the largest market share, and the Indian Artificial Kidney market was the rapid-growing market in the Asia-Pacific region.

Artificial Kidney Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development in order to spread their product lines, which will help the Artificial Kidney market grow even more. Market participants are also undertaking a various strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Artificial Kidney industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Artificial Kidney industry to benefit clients and increase the market sector. In recent years, the Artificial Kidney industry has offered some of the most significant advantages to medicine. Major players in the Artificial Kidney market, including Kawasumi Laboratories Inc., Blood Purification Technologies Inc., AWAK Technologies Pte. Ltd, Triomed AB, Asahi Kasei Medical Vo. Ltd, US Kidney Research Corporation, Merit Medical Systems, NIPRO Medical Corporation, Fresenius SE & Co. KGaA, and others are trying to increase market demand by investing in research and development operations.

The American Association of Kidney Patients (AAKP) is the largest and oldest independent organization kidney patient, founded in the year 1969. The programs provided by them inform and inspire patients and their families to understand condition of patient and adjust to their circumstances in their communities. It is commited in improving the quality of life for kidney patients via patient engagement, education, advocacy, and fostering of patient communities. In August 2018, they announced some plans to join patients' research efforts for the Kidney Project. This kidney project is an effort for the innovation and development of a free-standing bio-artificial kidney for treating End-Stage Renal Disease (ESRD).

AWAK is a patient-eccentric medical technology company that emphasizes improving the lives of dialysis patients and their caregivers by offering solutions to provide improved outcomes by improving their quality of life. AWAK Technologies has innovated portable dialysis machines using customized sorbet; the integrated infusion system is developed for kidney dialysis treatment, hemodialysis, and peritoneal dialysis. In December 2019, a highly-populated Singapore-based key player, AWAK Technologies, was included in the development of the artificial kidney market. They invested USD 40 million for the development of their wearable peritoneal dialysis devices that have received breakthrough designation from the FDA.

Key Companies in the Artificial Kidney market include

• 
  

  Kawasumi Laboratories Inc.

  
  


• 
  

  Blood Purification Technologies Inc.

  
  


• 
  

  AWAK Technologies Pte. Ltd

  
  


• 
  

  Trimmed AB

  
  


• 
  

  Asahi Kasei Medical Vo. Ltd

  
  


• 
  

  US Kidney Research Corporation

  
  


• 
  

  Merit Medical Systems

  
  


• 
  

  NIPRO Medical Corporation

  
  


• 
  

  Fresenius SE & Co. KGaA

  
  

Artificial Kidney Industry Developments

March 2022:KaraMD announced Pure Health Apple Cider Vinegar Gummies, a vegan gummy aimed to aid ketosis, digestion regulation, weight management, and encourage greater levels of energy.

January 2022:Solace Nutrition, a US-based medical nutrition company, bought R-Kane Nutritionals' assets for an unknown sum. This asset acquisition enables Solace Nutrition to develop synergy between both brands, accelerate growth, and establish a position in an adjacent nutrition sector. R-Kane Nutritionals is a firm established in the United States that specializes in high-protein meal replacement products for weight loss.

September 2021:The latest technology for purifying the blood of patients with End-Stage Renal Disease was introduced by the US Kidney Research Corporation. The development of the miniaturized implantable artificial kidneys was done using this technology; also developed wearable artificial kidneys and can offer real-time data.

Artificial Kidney Market Segmentation

Artificial Kidney Type Outlook

• 
  

  Wearable Artificial Kidney

  
  


• 
  

  Implantable Artificial Kidney

  
  

Artificial Kidney Dialysis Outlook

• 
  

  Hemodialysis

  
  


• 
  

  Peritoneal Dialysis

  
  

Artificial Kidney Regional Outlook

• 
  

  North America

  
  
  
  
  • US
  
  
  • Canada
  
  
  
  

• 
  

  Europe

  
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America